Shanthi GaneshDirector at Novo NordiskSpeaker
Agenda Sessions
Targeting Immune Cell PD-L1 with RNAi-Lipid Conjugates to Treat Refractory Cancer Patients
, 4:15pmView Session
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Targeting Immune Cell PD-L1 with RNAi-Lipid Conjugates to Treat Refractory Cancer Patients